NeuCyte Inc

Alexza Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The company's technology, the Staccato system, vaporizes unformulated drug compound to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza Pharmaceuticals has four product candidates in clinical development: AZ-001 (Staccato prochlorperazine) for the treatment of acute migraine headaches; AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder; AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia; and AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain. Alexza Pharmaceuticals is located in Palo Alto, Calif.

Argent Development Group is a real estate development firm with offices located on both the West Coast and East Coast of the United States. With a focus on delivering quality projects, the company operates from Mountain View, California, and Naples, Florida. Committed to creating innovative spaces, Argent Development Group leverages its expertise and local knowledge to meet the diverse needs of its clients. The firm engages in a variety of development initiatives, reinforcing its presence in the competitive real estate market. Generated from the website

SCILEX Holding Company is a pharmaceutical company based in Palo Alto, CA, specializing in non-opioid pain management solutions. Their product portfolio includes ZTlido, indicated for the relief of pain associated with post-herpetic neuralgia in adults, Elyxyb, a prescription nonsteroidal anti-inflammatory drug used for the acute treatment of migraine, and Gloperba, an oral solution for prophylaxis of gout flares in adults. With a focus on innovation and advanced technology, SCILEX Holding Company is committed to providing effective and safe alternatives for pain management. Their dedication to research and development is evident in their robust technology pipeline, ensuring a continuous stream of innovative solutions for patients in need.Generated from the website